metaphacts will be participating in the Augmented Intelligence in Drug Discovery Xchange, as part of the Digital Science team.

This Xchange brings together executives from pharma and biotech to address and find solutions to the key issues faced in AI-led drug discovery.

Discussion topics will cover Data Quality, Target Identification, Lead Generation & Optimization and Drug Response Prediction.

Digital Science contribution

Keynote presentation

The Future of AI in Pharma: Accelerating Research Workflows with GenAI

September 26, 08:30 am EST, Robert McGrath, Co-Founder & CEO - ReadCube (Digital Science)

In this keynote presentation, Robert will explore the transformative impact of Generative AI (GenAI) on research workflows and systematic literature reviews within the pharmaceutical industry. The discussion will focus on the evolving roles of researchers and the need to balance automation with human insight and will highlight how AI enhances research processes by augmenting human expertise, driving innovation, and advancing progress in pharma. Attendees will learn about the latest GenAI-driven tools, their integration into current workflows, and the ethical considerations involved.

Roundtable discussion

How can we bring fact-based knowledge and language together in AI applications for drug discovery?

September 26, 11:20 am EST, Peter Doerr, Director Presales - Solution Architecture and Strategy, metaphacts (Digital Science)

In this roundtable, Peter will guide participants through discussions on their experiences with the application of AI and focus on fields and use cases that show promising results. The discussion will try to address the question of how enterprises can bring fact-based knowledge and language together in their AI applications to support scientific work through trustworthy AI systems.